Table 1.
Demographic and Clinical Characteristics of Clinical Groups.
| Clinical group | ||||||||
|---|---|---|---|---|---|---|---|---|
| Variable | PS (n = 22) | CHR (n = 29) | HC (n = 17) | |||||
| % | M | SD | % | M | SD | % | M | SD |
| Demographics | ||||||||
| 86.4a | 44.8b | 52.9 | ||||||
| 11.4a | 2.8 | 13.5b | 2.7 | 11.0a | 4.2 | |||
| 95.2 | 79.3 | 94.1 | ||||||
| 13.6 | 6.9 | 5.9 | ||||||
| 75.6a | 27.9 | 89.6a | 13 | 107.1b | 20.9 | |||
| First-degree family mental health history d | ||||||||
| 14.3 | 4.4 | 0 | ||||||
| 14.3 | 21.7 | 0 | ||||||
| 4.8 | 17.4 | 11.8 | ||||||
| Medication use at assessment | ||||||||
| 50.0a | 260.3 | 382.8 | 27.6 | 149.1 | 107.6 | 0b | 0 | 0 |
| 45.5a | 31.1 | 0b | ||||||
| 18.2 | 6.9 | 0 | ||||||
| 4.5 | 3.5 | 0 | ||||||
| 4.5 | 0 | 0 | ||||||
Note: PS, psychosis; CHR, clinical high risk; HC, healthy control; SIB-R SS, Scales of Independent Behavior—Revised scaled scores.
Groups noted by different superscripted letters were significantly different in post hoc pairwise Student–Newman–Keuls (SNK) tests for continuous variables and Bonferroni corrected (p < .017) Fisher’s exact tests for categorical variables.
The SIB-R was administered to 20 PS participants, 21 CHR participants, and 16 HC participants.
One PS participant and six CHR participants were unable to provide information about family history of mental illness because they had limited contact with their biological parents or their adoptive parents were unsure of mental illness history among first-degree biological relatives.
Means and standard deviations are for chlorpromazine (CPZ) equivalence. Antipsychotic medications used (not mutually exclusive)included Risperidone (n = 10), Aripiprazole (n = 6), Clozapine (n = 2), Haloperidol(n = 1), Lurasidone (n = 1), Olanzapine (n = 1), and Ziprasidone (n = 1).